Sun Pharma: USFDA classifies Halol facility as Official Action Indicated Medical Dialogues Bureau30 March 2020 7:48 AM GMTMumbai: Sun Pharma has announced that the company has received communication from the USFDA indicating that the Halol facility has been classified as...
Sun Pharma nod to Rs 1,700 crore share buy-back offer at Rs 425 each Medical Dialogues Bureau17 March 2020 11:48 AM GMTNew Delhi: Indian Drug giant Sun Pharmaceutical Industries has announced that its board has approved Rs 1,700 crore share buyback offer at a...
Shortage of generic version of BP drug pindolol, says Sun Pharma Medical Dialogues Bureau3 March 2020 7:06 AM GMTThe coronavirus outbreak has disrupted international businesses dependent on Chinese supplies and industry experts expect Indian generic drugmakers to...
Sun Pharma plea to refix price of Ciprofloxacin Hydrochloride Injection rejected Farhat Nasim6 Jan 2020 7:45 AM GMTNew Delhi: In a major setback to Ranbaxy Laboratories Limited (now Sun Pharmaceutical Industries Ltd.), the Department of Pharmaceuticals (DoP) has...
NPPA fixes retail price of 59 combo drug formulations including Paracetamol, Metformin, Atorvastatin; Details Medical Dialogues Bureau15 Nov 2019 10:59 AM GMTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
NPPA fixes retail price of 14 drug formulations; Details Farhat Nasim13 Nov 2019 5:53 AM GMTNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
Sun Pharma carried out off-label promotions of 3 drugs-Ilumya, Yonsa, Absorica, alleges former employee Farhat Nasim10 Nov 2019 12:07 PM GMTNew Delhi: In a major setback to the country's largest drugmaker Sun Pharmaceuticals Ltd. (Sun Pharma), the firm has been accused of allegedly...
Sun Pharma signs licensing pact with AstraZeneca to introduce Novel Oncology products in China Medical Dialogues Bureau6 Nov 2019 7:56 AM GMTMumbai-Indian drugmaker giant Sun Pharma announced today about entering into an agreement with AstraZeneca to enter the Chinese market with novel...
Sun Pharma Advanced Research Company Q2 loss widens to Rs 63 cr Medical Dialogues Bureau5 Nov 2019 7:25 AM GMTNew Delhi: Sun Pharma Advanced Research Company (SPARC) on Monday reported a net loss of Rs 63.16 crore for the quarter ended September 30 of the...
FIRST: Sun Pharma unveils dry-eye treatment drug CEQUA in US Farhat Nasim14 Oct 2019 7:43 AM GMTNew Delhi: Through a release, drug major, Sun Pharmaceutical Industries Ltd. (Sun Pharma) today announced that one of its wholly-owned subsidiaries...
Sun Pharma ILUMYA phase 3 trial shows significant skin clearance in people with Plaque Psoriasis Farhat Nasim11 Oct 2019 4:00 AM GMTNew Delhi: Sun Pharmaceutical Industries Ltd. recently announced that one of its wholly-owned subsidiaries presented long-term follow-up data from...
SPARC neonatal seizures drug Phenobarbital gets Orphan Drug Designation from USFDA Farhat Nasim5 Oct 2019 6:30 AM GMTOrphan Drug Designation will grant seven years of US market exclusivity upon approval of Phenobarbital for the treatment of patients with neonatal...
